Vaccination to Protect Against Proteus mirabilis Challenge Utilizing the Ascending Model of Urinary Tract Infection

Area of Science:

• Microbiology
• Immunology
• Vaccinology

Background:

• Proteus mirabilis causes complicated urinary tract infections (UTIs).
• Urease activity of P. mirabilis raises urine pH, leading to stone formation (urolithiasis).
• Urolithiasis complicates UTIs, causing blockages, sepsis, and treatment resistance.

Purpose of the Study:

• To develop a mucosal vaccine against P. mirabilis UTIs.
• To conjugate a P. mirabilis antigen to cholera toxin for enhanced immunogenicity.
• To evaluate intranasal vaccine administration and efficacy in a murine model.

Main Methods:

• Production of a vaccine candidate using P. mirabilis components conjugated to cholera toxin.
• Intranasal administration of the vaccine in a murine model.
• Testing vaccine efficacy in a transurethral P. mirabilis infection model.

Main Results:

• Methodology for producing the P. mirabilis-cholera toxin conjugate vaccine is described.
• Intranasal delivery and efficacy testing protocols are established.
• The study provides a framework for evaluating mucosal vaccine candidates against P. mirabilis.

Conclusions:

• A mucosal vaccine strategy is critical for combating P. mirabilis UTIs.
• The described methodology facilitates the development and testing of novel vaccine candidates.
• This research paves the way for effective prevention of P. mirabilis-associated urolithiasis and septicemia.